| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7db23a3fe5d392e2dd35e3f45e9d4468 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2006-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8cbb3bd4482dcf1b26816854d966c4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16579aef1dc9ab0e92e804164979580c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_398f2545584a45d18907c58384acf8f9 |
| publicationDate |
2007-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2007010754-A |
| titleOfInvention |
DEFIBROTIDE AND / OR OLIGODEOXIRIBONUCLEOTIDOS TO TREAT DEPENDENT TUMORS OF ANGIOGENESIS. |
| abstract |
The use of Defibrotide and / or oligodeoxyribonucleotides having a molecular weight of 4000-10000 Daltons (atomic mass units) as an anti-tumor agent, alone or in combination with other active ingredients with anti-tumor action is described. The oligotide can be produced by extracting animal and / or plant tissues, in particular from mammalian organs or can be produced synthetically. Tumors that can be treated are preferably angiogenesis-dependent tumors, such as multiple myeloma or breast carcinoma. |
| priorityDate |
2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |